DE69531305D1 - Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten - Google Patents

Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten

Info

Publication number
DE69531305D1
DE69531305D1 DE69531305T DE69531305T DE69531305D1 DE 69531305 D1 DE69531305 D1 DE 69531305D1 DE 69531305 T DE69531305 T DE 69531305T DE 69531305 T DE69531305 T DE 69531305T DE 69531305 D1 DE69531305 D1 DE 69531305D1
Authority
DE
Germany
Prior art keywords
salts
active component
compositions containing
antibacterial compositions
carboxylate derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69531305T
Other languages
English (en)
Other versions
DE69531305T2 (de
Inventor
Akira Yazaki
Jiro Yoshida
Yoshiko Niino
Yoshihiro Ohshita
Norihiro Hayashi
Hirotaka Amano
Yuzo Hirao
Yasuhiro Kuramoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Publication of DE69531305D1 publication Critical patent/DE69531305D1/de
Application granted granted Critical
Publication of DE69531305T2 publication Critical patent/DE69531305T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
DE69531305T 1994-10-20 1995-10-20 Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten Expired - Fee Related DE69531305T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP25504694 1994-10-20
JP25504694 1994-10-20
JP1267395 1995-01-30
JP1267395 1995-01-30
PCT/JP1995/002156 WO1996012704A1 (fr) 1994-10-20 1995-10-20 Nouveau derive de pyridone-carboxylate, ou sel de celui-ci, et antibacterien le contenant comme principe actif

Publications (2)

Publication Number Publication Date
DE69531305D1 true DE69531305D1 (de) 2003-08-21
DE69531305T2 DE69531305T2 (de) 2004-05-13

Family

ID=26348315

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69531305T Expired - Fee Related DE69531305T2 (de) 1994-10-20 1995-10-20 Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten

Country Status (4)

Country Link
US (1) US5910498A (de)
EP (1) EP0787720B1 (de)
DE (1) DE69531305T2 (de)
WO (1) WO1996012704A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69628466T2 (de) * 1995-09-22 2004-04-01 Wakunaga Pharmaceutical Co., Ltd. Zwischenverbindungen zur Herstellung von neunen Pyridoncarbonsäurederivate oder deren Salzen
EP0897909A1 (de) * 1996-04-16 1999-02-24 Wakunaga Pharmaceutical Co., Ltd. Phenylendiamine und verfahren zu deren herstellung
PT897919E (pt) * 1996-04-19 2004-11-30 Wakunaga Pharma Co Ltd Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US6297248B1 (en) * 1997-04-06 2001-10-02 Suntory Limited 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor
WO2000076556A2 (en) * 1999-06-11 2000-12-21 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
JP3477466B2 (ja) * 1999-09-02 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
US6815438B2 (en) 1999-12-14 2004-11-09 Neurosearch A/S Heteroaryl-diazabicycloalkanes
ES2292642T3 (es) * 2000-11-20 2008-03-16 Daiichi Sankyo Company, Limited Compuestos deshalogenados.
AU2002249935A1 (en) 2001-01-08 2002-08-19 Neorx Corporation Radioactively labelled conjugates of phosphonates
AU2002364552A1 (en) 2001-12-13 2003-06-30 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
WO2017217441A1 (ja) 2016-06-15 2017-12-21 湧永製薬株式会社 新規ピリドンカルボン酸誘導体又はその塩
JOP20190086A1 (ar) 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
JPS5531042A (en) * 1978-08-25 1980-03-05 Dainippon Pharmaceut Co Ltd 1,8-naphthylidine derivative and its salt
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS60228479A (ja) * 1984-04-26 1985-11-13 Toyama Chem Co Ltd １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
GB8524662D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinolone compounds
JPH0348682A (ja) * 1989-07-14 1991-03-01 Yoshitomi Pharmaceut Ind Ltd ピリドンカルボン酸化合物
JPH0366688A (ja) * 1989-08-03 1991-03-22 Yoshitomi Pharmaceut Ind Ltd １，４―ジヒドロ―４―オキソナフチリジン化合物
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel

Also Published As

Publication number Publication date
EP0787720A1 (de) 1997-08-06
WO1996012704A1 (fr) 1996-05-02
US5910498A (en) 1999-06-08
EP0787720B1 (de) 2003-07-16
DE69531305T2 (de) 2004-05-13
EP0787720A4 (de) 1999-02-03

Similar Documents

Publication Publication Date Title
DE69531305D1 (de) Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
DE69526958D1 (de) Antibakterielle oder bakterizide mittel, die 2-aminothiazolderivate und deren salze enthalten
DE3577398D1 (de) Teilchenzusammensetzung und deren verwendung als antimikrobielles mittel.
DE69711640D1 (de) Naphthopyrane, zusammensetzungen und artikel die diese enthalten
DE69110561D1 (de) Mittel zur Behandlung und Vorbeugung von Bauchentzündungen, die als Wirkstoff Zink-L-Carnosin-Salze oder -Komplexe enthalten.
HU9402817D0 (en) Compounds for treating allergic and inflammatory diseases
DE3689436D1 (de) Thiazolderivate und diese als wirksame Bestandteile enthaltender Leukotrien-Antagonist.
DE69424173D1 (de) Carbodiimide-Verbindungen und dauerhafte wasserabweisende Zusammensetzungen, die diese Verbindungen enthalten
BR9106438A (pt) Composicoes terapeuticas sinergisticas e processos
DE69323387D1 (de) Oberflächenaktive Polyacrylate und Zusammensetzungen, die diese enthalten
DE69207114D1 (de) Phenylmethoxyiminoverbindungen und landwirtschaftliche Fungizide, die sie enthalten
ATA95989A (de) Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten
DE69501341D1 (de) Sulfoniumsalz und Resistzusammensetzung
ATE252883T1 (de) Schweisshemmende mittel und zusammensetzungen die diese enthalten
DE69228738D1 (de) Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
DE69524871D1 (de) Benzopyrans und deren verwendung als therapeutische mittel
KR960705557A (ko) 항미생물 방법 및 화장품 조성물(antimicrobial method and cosmetic composition)
DE69531722D1 (de) Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
DE68925848D1 (de) Cephemverbindung als bakterizides Mittel und seine Herstellung
NO934426L (no) Nye amidoalkyl- og imidoalkyl-piperaziner
DE69401151D1 (de) Indenderivate und antimikrobe Mittel, die diese Indenderivate als Aktivkomponente enthalten
DE69125801D1 (de) Cis-Gamma-Butyrolacton-Verbindungen und diese enthaltende Zusammensetzung
DE69408935D1 (de) Piperidinylphosphitzusammensetzungen und Polyolefinzusammensetzungen die diese enthalten
DE69528261D1 (de) Benzopyrane und deren verwendung als therapeutische mittel
DE69426277D1 (de) Stabilisator und thermoplastische Zusammensetzungen, die diese enthalten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee